News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
145 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21249)
Month
January (2935)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
2 (21)
3 (149)
4 (290)
5 (295)
6 (241)
7 (145)
10 (297)
11 (166)
12 (61)
13 (229)
14 (184)
17 (126)
18 (144)
19 (137)
20 (141)
21 (143)
24 (150)
25 (65)
26 (125)
27 (69)
28 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Press Releases
Travere Therapeutics Announces Late-Breaking Data from Phase 3 DUPLEX Study of FILSPARI in FSGS Presented at the American Society of Nephrology (ASN) Kidney Week 2025
November 7, 2025
·
18 min read
Opinion
The GLP-1 Paradox—Why Is a $95B Obesity Market Ignoring Its Biggest Problem?
The nausea and other gastrointestinal side effects of weight loss drugs like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound will limit how much these drugs can help patients and stunt the overall obesity market unless we approach the problem head on.
November 7, 2025
·
5 min read
·
James O’Mara
Press Releases
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
November 7, 2025
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
November 7, 2025
·
5 min read
Press Releases
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
November 7, 2025
·
4 min read
Press Releases
Elixir Medical Highlights Results From “Real World” MY-IVL Study Demonstrating Performance of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Treating Calcified Coronary Lesions
November 7, 2025
·
4 min read
Press Releases
Breakthrough T1D Encouraged by Promising Results of FINE-ONE Phase 3 Clinical Trial Evaluating Finerenone for Chronic Kidney Disease Associated with Type 1 Diabetes
November 7, 2025
·
2 min read
Press Releases
Cryoport Systems Wins 2025 BioTech Breakthrough Award For “BioServices Innovation of the Year”
November 7, 2025
·
5 min read
Press Releases
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
November 7, 2025
·
2 min read
Press Releases
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
November 7, 2025
·
5 min read
Previous
12 of 15
Next